![Eugene Sun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eugene Sun
Keine laufenden Positionen mehr
Profil
Eugene Sun served as the Chief Executive Officer & Director at Melinta Subsidiary Corp.
from 2015 to 2017.
He was also the Independent Director at NVN Liquidation, Inc. from 2018 to 2020.
Prior to that, he was the VP-Global Pharmaceutical Clinical Development at Abbott Laboratories from 2000 to 2011 and the Director at TAP Pharmaceutical Products, Inc. in 2008.
Dr. Sun received his undergraduate degree from Harvard University and his doctorate from New York University School of Medicine.
Ehemalige bekannte Positionen von Eugene Sun
| Unternehmen | Position | Ende |
|---|---|---|
| NVN LIQUIDATION, INC. | Direktor/Vorstandsmitglied | 29.01.2020 |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Vorstandsvorsitzender | 01.01.2017 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 24.08.2012 |
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2008 |
Ausbildung von Eugene Sun
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets pharmaceutical products | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
